Another solid announcement, ticking one box after another.
This sponsored research agreement will help speed up the process towards the phase1 trial for 2101, with the University of Pennsylvania being one of the best in the states.
We have plenty of shots on goal with the three current platforms, patience will be rewarded handsomely in the long run.
- Forums
- ASX - By Stock
- CHM
- Ann: Sponsored Research Agreement with University of Pennsylvania
CHM
chimeric therapeutics limited
Add to My Watchlist
12.5%
!
0.5¢

Ann: Sponsored Research Agreement with University of Pennsylvania, page-3
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.5¢ |
Change
0.001(12.5%) |
Mkt cap ! $9.068M |
Open | High | Low | Value | Volume |
0.4¢ | 0.5¢ | 0.4¢ | $3.336K | 821.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 3970217 | 0.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.5¢ | 18599873 | 22 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 3970217 | 0.004 |
41 | 27362937 | 0.003 |
16 | 15400505 | 0.002 |
12 | 54600000 | 0.001 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.005 | 18599873 | 22 |
0.006 | 13884684 | 16 |
0.007 | 3100000 | 2 |
0.008 | 8542434 | 6 |
0.009 | 2327672 | 4 |
Last trade - 10.26am 26/06/2025 (20 minute delay) ? |
Featured News
CHM (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
Previous Video
Next Video
SPONSORED BY The Market Online